fda tirzepatide compounding Breaking News: Pharmacies Take the Fight to the Fifth Circuit The Outsourcing Facilities Association (OFA) has filed an appeal challenging the FDA's decision to restrict compounding pharmacies from producing tirzepatide, the Update from Big Easy on

Boehringer Ingelheim was given the opportunity to review the manuscript for medical and scientific accuracy as well as intellectual property considerations

Note that this product has been associated with rare cases of liver toxicity, and many clinicians are no longer prescribing it

These preparations receive the shortest BUDs, often 12 to 24 hours at room temperature or 24 hours refrigerated, though multi-dose vials with preservatives may receive longer dates

Consistently, electrophysiological recordings showed that liraglutide increases the EPSCs frequency of POMC neurons suggesting the modulation of presynaptic excitatory synaptic transmission (He et al., 2019)

Because of this connection, researchers are exploring whether therapies designed to improve metabolic health could also support neurological function